Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04881903 · ClinicalTrials.gov registry record · NA
Developing a Mobile Intervention to Reduce Suicidal Cognitions in Veterans
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04881903: Completed NA study, sponsored by VA Office of Research and Development.
NCT04881903 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04881903, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Suicide cognitions are conceptualized as enduring, chronic vulnerability factors that predispose individuals to suicidal crises. Therefore, modification of these beliefs may reduce suicidal thoughts and behaviors. The goal of this research is to develop, refine, and pilot-test a mobile intervention to reduce cognitions that contribute to elevated suicide risk and to assess the impact of reductions in suicide cognitions and anger cognitions on suicide risk and functioning.
Primary Outcome
Participant feasibility expectation will be met if recruitment is 75% (i.e., N = 8) or greater of recruitment expectation (N = 10).
Interventions
- BEHAVIORAL Mobile Intervention for Reducing Anger (MIRA)
- BEHAVIORAL Mobile Intervention for Suicidal Thoughts (MIST)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2024-02-01 |
| Phase | NA |
What the finished NCT04881903 record still lists
NCT04881903 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Mobile Intervention for Reducing Anger (MIRA) is the first listed.
NCT04881903 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04881903 about?
NCT04881903 is a clinical study titled "Developing a Mobile Intervention to Reduce Suicidal Cognitions in Veterans". Suicide cognitions are conceptualized as enduring, chronic vulnerability factors that predispose individuals to suicidal crises. Therefore, modification of these beliefs may reduce suicidal thoughts and behaviors. The goal of this research is to develop, refine, and pilot-test a mobile intervention ...
What is the current status of trial NCT04881903?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-12-01. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT04881903?
The interventions under investigation include: Mobile Intervention for Reducing Anger (MIRA) (BEHAVIORAL), Mobile Intervention for Suicidal Thoughts (MIST) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04881903?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04881903's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI